Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

July 7, 1997

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Cholinesterase inhibition with metrifonate studied in rats

July 4, 1997

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

TIMI-IIA finds enoxaparin promising

July 1, 1997

Epilepsy monotherapy approved in Canada

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...